title: [Efficacy of ANTISTAX in treatment of postmastectomic oedema of the upper limb].
abstract: Analysed herein are the results of two-year treatment with Antistax of 50 female patients presenting with early stages of upper limb lymphedema (the 'preclinical' stage of 'transient' oedemas, mild-oedema stage). The control group consisted of patients who due to various circumstances received no regular treatment with agents decreasing limb oedema, including diuretics. The obtained results demonstrated undoubted efficacy of Antistax administered at early stages of postmastectomic lymphedema. Preventive administration of the agent makes it possible to delay and in the majority of cases to also prevent the development of lymphedema. Administration of Antistax in a combination with physiotherapeutic treatment makes it possible both in the first and second stages of the disease to preserve the cosmetic and functional state of the upper limb.
authors.forename: M O
authors.initials: MO
authors.lastname: Miasnikova
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage / Q000009:adverse effects; D001943:Breast Neoplasms / Q000601:surgery*; D061345:Early Medical Intervention; D005260:Female; D006801:Humans; D008209:Lymphedema / Q000188:drug therapy / Q000503:physiopathology; D015409:Mastectomy, Radical / Q000009:adverse effects*; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy* / Q000503:physiopathology; D011794:Quercetin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D034941:Upper Extremity / Q000503:physiopathology*
chemical_list: D000975:Antioxidants; C522873:Antistax; D011794:Quercetin